Rx Hydroquinone Skin Bleach Regulatory Controls Sought By Galderma
This article was originally published in The Rose Sheet
Executive Summary
Galderma Labs calls for stricter FDA enforcement over unapproved marketed prescription drugs and new requirements for disclosure regarding the lack of approval in recent comments to the agency
You may also be interested in...
FDA Notice Of Proposed Rulemaking On Hydroquinone Slated For June
The Center for Drug Evaluation & Research's Division of OTC Drug Products plans to publish a notice of proposed rulemaking on hydroquinone, a cosmetic ingredient frequently used in skin brightening products, in June, FDA reported in its unified regulatory agenda, published in a Dec. 13 Federal Register 1notice
OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"
With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program